Two peptides from sea cucumber—GGPGDR and WGNEEF—successfully blocked the enzyme that produces uric acid in laboratory tests, with GGPGDR being 2.3 times more potent. According to Gram Research analysis, both peptides also demonstrated strong antioxidant activity and didn’t harm human cells, suggesting sea cucumber could become a natural ingredient for managing gout and high uric acid levels, though human studies are still needed.
Researchers discovered two special protein fragments from sea cucumber that may help reduce uric acid buildup in the body. Using computer modeling and lab tests, scientists identified peptides called GGPGDR and WGNEEF that block an enzyme responsible for uric acid production. These peptides showed strong antioxidant properties and didn’t harm human cells in testing. The findings suggest sea cucumber could become a natural ingredient in supplements or functional foods for people with gout or high uric acid levels, though human studies are still needed to confirm effectiveness.
Key Statistics
A 2026 laboratory study published in the Journal of Food Science found that the peptide GGPGDR from sea cucumber inhibited xanthine oxidase with an IC50 value of 1.09 mg/mL, making it 2.3 times more potent than the peptide WGNEEF.
The sea cucumber peptide WGNEEF neutralized 99.01% of hydroxyl free radicals at a concentration of 1.2 mg/mL, demonstrating exceptional antioxidant capacity in laboratory testing.
Both GGPGDR and WGNEEF peptides maintained human liver cell viability above 80% in toxicity testing, indicating acceptable biocompatibility for potential use as functional food ingredients.
The Quick Take
- What they studied: Whether special protein pieces from sea cucumber could block the enzyme that creates uric acid in our bodies
- Who participated: This was a laboratory study using computer models and cell cultures, not human volunteers. Researchers tested two peptides (GGPGDR and WGNEEF) extracted from sea cucumber proteins
- Key finding: Both peptides successfully blocked the uric acid-producing enzyme, with GGPGDR being more effective. The peptides also acted as antioxidants and didn’t damage human liver cells
- What it means for you: Sea cucumber peptides might eventually become a natural supplement option for gout or high uric acid, but human clinical trials are needed first to prove safety and effectiveness in real people
The Research Details
Scientists used a three-step approach to find helpful peptides from sea cucumber. First, they used computer programs to screen thousands of protein fragments, looking for ones that could stick to and block xanthine oxidase—the enzyme that makes uric acid. They filtered candidates based on water solubility, safety, and binding strength. Second, they synthesized the two most promising peptides (GGPGDR and WGNEEF) in the lab. Third, they tested these peptides in test tubes and with human liver cells to measure their effectiveness and safety.
The researchers used advanced computer simulations called molecular dynamics to understand how these peptides interact with the target enzyme at a molecular level. This helped explain why GGPGDR worked better than WGNEEF. They also measured antioxidant activity—the peptides’ ability to neutralize harmful free radicals—using multiple testing methods.
This approach combines computational prediction with experimental validation, which is a reliable way to identify promising natural compounds before investing in expensive human trials.
Computer-aided screening saves time and money by narrowing down thousands of candidates to the most promising ones before lab testing. This approach is especially valuable for discovering bioactive compounds from natural sources like sea cucumber, which contains hundreds of different proteins. By combining computer modeling with actual lab experiments, researchers can understand not just whether something works, but how and why it works at the molecular level.
Strengths: The study used multiple complementary testing methods (computer docking, molecular dynamics, enzyme assays, antioxidant assays, and cell toxicity tests), which increases confidence in the findings. The researchers tested both peptides and compared their effectiveness. Limitations: This is laboratory research only—no human studies were conducted. The sample size for cell testing wasn’t specified. Results from test tubes don’t always translate to human bodies. The study doesn’t tell us how much sea cucumber you’d need to eat or whether the peptides survive digestion.
What the Results Show
Both peptides successfully inhibited xanthine oxidase, the enzyme responsible for uric acid production. GGPGDR was the stronger inhibitor with an IC50 value of 1.09 mg/mL (meaning this concentration blocked 50% of enzyme activity), while WGNEEF had an IC50 of 2.52 mg/mL. In practical terms, GGPGDR was about 2.3 times more potent than WGNEEF.
Both peptides also demonstrated antioxidant activity in a dose-dependent manner, meaning higher concentrations worked better. WGNEEF showed particularly impressive free radical scavenging, neutralizing 37.59% of DPPH radicals, 73.69% of ABTS+ radicals, and 99.01% of hydroxyl radicals at the highest concentration tested (1.2 mg/mL).
When tested with human liver cells, both peptides showed excellent safety profiles. Cell viability remained above 80% even at the highest concentrations tested, suggesting the peptides are unlikely to be toxic to human cells. Computer simulations showed that GGPGDR formed a more stable complex with the target enzyme, with stronger and more persistent molecular interactions.
The molecular dynamics simulations revealed that GGPGDR maintained a more compact and stable structure when bound to xanthine oxidase, with lower RMSD values (a measure of structural flexibility). This structural stability likely explains why GGPGDR was more effective at blocking the enzyme. The hydrogen bonding patterns—the molecular ‘glue’ holding the peptide to the enzyme—were more persistent with GGPGDR, suggesting a longer-lasting effect.
This research builds on growing interest in bioactive peptides from marine sources for managing hyperuricemia (high uric acid). Previous studies have identified various peptides with enzyme-inhibiting properties, but this is among the first to comprehensively characterize sea cucumber peptides using integrated computational and experimental approaches. The potency of these peptides (IC50 values in the 1-2.5 mg/mL range) is comparable to or better than some previously identified peptides from other marine sources.
This study was conducted entirely in laboratory conditions using isolated enzymes and cell cultures—not living organisms or humans. The peptides were tested at relatively high concentrations (up to 1.2 mg/mL), and it’s unclear whether these concentrations are achievable through eating sea cucumber or taking supplements. The study doesn’t address whether these peptides survive stomach acid and digestion. No information was provided about optimal dosing, duration of treatment, or potential interactions with medications. Long-term safety and effectiveness in humans remain unknown.
The Bottom Line
These findings are promising but preliminary. According to Gram Research analysis, sea cucumber peptides show potential as a natural ingredient for managing uric acid levels, but human clinical trials are essential before making health claims. Current evidence supports further research and development, not yet consumer use. If you have gout or high uric acid, discuss any sea cucumber supplements with your doctor before trying them, especially if you take uric acid-lowering medications.
People with gout, hyperuricemia (high uric acid), or those interested in natural approaches to managing these conditions should follow this research. Healthcare providers treating uric acid-related conditions may eventually recommend sea cucumber-derived supplements once human studies confirm safety and effectiveness. This research is less relevant for people without uric acid concerns. Anyone taking allopurinol or other uric acid medications should consult their doctor before adding sea cucumber supplements.
This is early-stage research. Realistic timeline: 2-5 years for human clinical trials if funding is secured, 5-10 years before products might reach the market with health claims, and 10+ years before widespread medical adoption. Don’t expect immediate availability of proven sea cucumber peptide supplements.
Frequently Asked Questions
Can sea cucumber peptides help with gout?
Laboratory research shows sea cucumber peptides block the enzyme that creates uric acid, suggesting potential benefits for gout management. However, human clinical trials haven’t been conducted yet, so effectiveness in real people remains unproven. Consult your doctor before trying sea cucumber supplements alongside gout medications.
What are xanthine oxidase inhibitors and why do they matter?
Xanthine oxidase is the enzyme your body uses to produce uric acid. Inhibitors block this enzyme, reducing uric acid buildup that causes gout and joint pain. Common medications like allopurinol work this way. Sea cucumber peptides appear to work similarly but naturally.
How much sea cucumber would I need to eat to get these benefits?
Unknown. This study tested isolated peptides at high concentrations in the lab. It’s unclear how much sea cucumber you’d need to consume, whether cooking affects the peptides, or if they survive digestion. Human studies would answer these practical questions.
Are sea cucumber peptides safe to take?
Laboratory testing showed both peptides didn’t damage human liver cells, suggesting safety. However, this doesn’t guarantee safety in living people. Long-term effects, interactions with medications, and appropriate dosages haven’t been studied in humans yet.
When will sea cucumber supplements be available for gout?
This research is preliminary. Human clinical trials would need to occur first (2-5 years minimum), followed by regulatory approval and product development. Realistic timeline is 5-10 years before any sea cucumber peptide products might reach the market with health claims.
Want to Apply This Research?
- Track serum uric acid levels monthly (via blood tests) if you begin using sea cucumber supplements, recording the date, uric acid value, and any gout symptoms experienced that week
- Set a reminder to consistently consume sea cucumber or a derived supplement at the same time daily, logging intake in the app along with any changes in joint pain, swelling, or gout attacks
- Create a symptom log tracking frequency and severity of gout flares, joint stiffness, and energy levels over 8-12 weeks to assess whether sea cucumber peptides provide noticeable benefits beyond lab measurements
This research describes laboratory findings only and has not been tested in humans. Sea cucumber peptides are not approved by the FDA for treating gout or high uric acid levels. Do not use sea cucumber supplements as a replacement for prescribed uric acid-lowering medications like allopurinol without consulting your healthcare provider. If you have gout, hyperuricemia, or kidney disease, discuss any dietary supplements with your doctor before use, as they may interact with medications or affect your condition. This article is for educational purposes and should not be considered medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.